CONMED CORPORATION Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year
CONMED CORPORATION (CNMD) had Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year of $2.80 million as of 2019-12-31, per its 10-K filed 2020-02-24.
Discontinued › Notes › Compensation Related Costs › Defined Benefit Plan
us-gaap:DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear · last filed 2020-02-24
- 2019-12-31: Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year $2.80M.
- 2018-12-31: Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year $2.90M.
- 2017-12-31: Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year $2.70M.
| Period end | Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year |
|---|---|
| 2019-12-31 | $2.80M 10-K · filed 2020-02-24 |
| 2018-12-31 | $2.90M 10-K · filed 2019-02-25 |
| 2017-12-31 | $2.70M 10-K · filed 2018-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |